A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease

被引：77
|
作者：
Checkoway, H
Franklin, GM
Costa-Mallen, P
Smith-Weller, T
Dilley, J
Swanson, PD
Costa, LG
机构：
[1] Univ Washington, Dept Environm Hlth, Seattle, WA 98195 USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
来源：
NEUROLOGY | 1998年 / 50卷 / 05期
关键词：
D O I：
10.1212/WNL.50.5.1458
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In a population-based case-control study, we found a reversal of the association of cigarette smoking with Parkinson's disease (PD) in relation to the monoamine oxidase B intron 13 genetic polymorphism. A reduced PD risk related to pack-years of smoking was detected for persons with the G allele, whereas an opposite effect was found among persons with the A allele. These results indicate an unexplained interaction between cigarette smoking and this genetic polymorphism.
引用
收藏
页码：1458 / 1461
页数：4
相关论文
共 50 条
  • [41] Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking
    Lerman, C
    Shields, PG
    Main, D
    Audrain, J
    Roth, J
    Boyd, NR
    Caporaso, NE
    PHARMACOGENETICS, 1997, 7 (06): : 521 - 524
  • [42] Parkinson's disease mortality and cigarette smoking
    Chen, HL
    Zhang, SMM
    Schwarzschild, MA
    Betensky, R
    Hernán, MA
    Ascherio, A
    NEUROLOGY, 2005, 64 (06) : A262 - A262
  • [43] Family-based association study of cigarette smoking and Parkinson's disease
    Scott, WK
    Caltagirone, RA
    Carney, RM
    Dills, SK
    Stajich, JM
    Vance, JM
    MOVEMENT DISORDERS, 2002, 17 : S148 - S149
  • [44] MAO-B AND PARKINSONS-DISEASE
    STURMAN, SG
    STEVENTON, GB
    WARING, RH
    WILLIAMS, AC
    MOVEMENT DISORDERS, 1990, 5 (04) : 338 - 339
  • [45] Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease
    Lyytinen, J
    Kaakkola, S
    Ahtila, S
    Tuomainen, P
    Teravainen, H
    MOVEMENT DISORDERS, 1997, 12 (04) : 497 - 505
  • [46] Long-term safety and efficacy of a novel MAO-B inhibitor in the treatment of Parkinson's disease
    Lew, MF
    ANNALS OF NEUROLOGY, 2005, 58 : S54 - S54
  • [47] Association between cigarette smoking and Parkinson's disease: A meta-analysis
    Li, Xiao
    Li, Weihua
    Liu, Guixia
    Shen, Xu
    Tang, Yun
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2015, 61 (03) : 510 - 516
  • [48] Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc Analysis
    Giladi, Nir
    Asgharnejad, Mahnaz
    Bauer, Lars
    Grieger, Frank
    Boroojerdi, Babak
    JOURNAL OF PARKINSONS DISEASE, 2016, 6 (02) : 401 - 411
  • [49] Rasagiline, a new selective MAO-B inhibitor with neuroprotective effect in vitro and in human Parkinson's disease
    Finberg, J. P. M.
    INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 : 115 - 115
  • [50] Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson’s disease
    Müller T.
    Riederer P.
    Grünblatt E.
    Journal of Neural Transmission, 2017, 124 (6) : 745 - 748
12345